A-Labs Advisory & Finance

Name

A-Labs Advisory & Finance

Legal name

A-Labs Finance & Advisory Ltd.

Website

https://alabs.co

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Investment Banking & Corporate Finance Advisory

NAICS

Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

Corporate Finance & Capital Advisory (BPAHADAB)

akta.pro secondary industries

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE), Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL), Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps) (FSAEAGAE)

Keywords

• Investment banking
• Corporate finance advisory
• Mergers and acquisitions
• Initial public offerings
• Strategic management advisory

Headquarters

HQ city

Kadima

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Advisory Services: Hands-on strategic advisory services where A-Labs becomes an extension of the client's management team. Services include strategic planning, business development, branding, investor relations, public relations, corporate governance, and taxation guidance.
2. Capital Markets Services: IPO execution, Reverse Takeovers (RTOs), Regulated Coin Offerings (RCOs), and public vehicle structures (SPACs/CPCs). Revenue appears to be transaction-based, tied to successful capital raises and listings.
3. M&A Advisory: Buy/sell side M&A advisory including pre-IPO mergers, synergy analysis, and merger execution. A-Labs takes a 'Give vs. Take' approach to value creation in transactions.
4. Mezzanine and Pre-IPO Financing: Direct investment in client companies combined with cooperation with global funds for pre-IPO stages, supporting with CLAs and other pre-IPO vehicles.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

A-Labs Advisory & Finance is a privately-held Israeli banking and advisory house (founded 2017) that delivers corporate finance and strategic advisory services to companies seeking capital markets access. Its core offerings include Corporate Finance (IPOs, RTOs, Regulated Coin Offerings, mezzanine/pre-IPO financing, SPACs/CPCs), Strategic Advisory (valuation, branding, IR, PR, business development, governance, taxation), and Mergers & Acquisitions advisory (sell-side, buy-side, and capital raising for M&A).

Product overview

A-Labs Advisory & Finance is a banking and advisory house operating worldwide with a suite of integrated corporate finance services. The offering comprises three core pillars: Corporate Finance (covering IPOs, RTOs, RCOs, mezzanine/pre-IPO financing, and SPACs/CPCs), Strategic Advisory (including valuation analysis, business model development, corporate branding, investor relations, public relations, and governance), and Mergers & Acquisitions (with buy/sell side advisory and synergy plays). The company positions itself as an active management team extension rather than passive advisors, focusing on companies with billion-dollar unicorn potential across sectors including hi-tech, pharma, fintech, biotech, and medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Corporate Finance

Quantifiable outcome

• 70-100 investors typically reached per global roadshow engagement
• +2 more outcomes

Named customers24 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Global Exchanges (NASDAQ, LSE, TSX, INX)coreStrategic or Co-development PartnerA-Labs operates directly with the world's largest exchanges including NASDAQ, LSE, TSX, and INX for IPO execution and the entire listing process including full regulatory oversight and compliance. These relationships enable end-to-end public offering services for clients.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• H.C. Wainwright & Co. Boutique investment bank active in IPOs, PIPEs, RTOs, and M&A for emerging growth and life sciences issuers. Closely aligned with A-Labs in serving unicorn-potential companies, executing non-traditional public listings, and operating relationship-driven transaction models.
• WestPark Capital: Boutique investment bank providing IPO, M&A, and private placement services to emerging growth companies. Comparable in scale, deal type, and the unicorn-potential client archetype A-Labs targets.
• Maxim Group: Boutique investment bank focused on emerging growth companies, IPOs, PIPEs, and M&A. Directly comparable to A-Labs on target issuer size, transaction type mix, and heavy reliance on equity capital markets work.
• Roth Capital Partners: US boutique investment bank focused on IPOs, follow-ons, and M&A for small- and mid-cap companies. Highly comparable to A-Labs given overlapping target client profile (growth/unicorn-potential issuers), full-service capital markets capability, and emphasis on senior-led execution.
• EF Hutton (formerly known as Kingswood Capital Markets / BR Holdings): Boutique full-service investment bank focused on small- and mid-cap M&A, capital raising, and IPO advisory. Comparable in client profile and product breadth across equity capital markets and strategic advisory.
• Aegis Capital Corp. Boutique full-service broker-dealer with ECM, M&A, and corporate advisory practices aimed at small/mid-cap issuers. Directly comparable to A-Labs on transaction size, target issuer profile, and product breadth in equity capital markets.
• Dawson James Securities: Boutique investment bank focused on healthcare, life sciences, and growth-company capital markets. Comparable to A-Labs given the convergent focus on growth/unicorn-potential issuers and sector-heavy issuance models.
• Network 1 Financial Securities: Boutique investment bank focused on emerging growth and technology issuers, providing IPO, follow-on, and M&A services. Comparable to A-Labs on boutique scale, growth-issuer focus, and full-stack ECM offerings.
• Galaxy Digital: Crypto-native financial services firm with institutional capital markets, advisory, and trading capabilities across digital assets. Closely aligned with A-Labs on the security token / regulated coin offering pioneering work (e.g., INX) and serving token issuers at IPO.
• Chardan Capital Markets: Boutique investment bank with notable specialization in SPACs and IPOs for emerging growth companies. Directly comparable on the RTO/SPAC/CPC product set and the unicorn-potential issuer thesis that anchors A-Labs' marketing.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/a-labs-finance

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about A-Labs Advisory & Finance